Related Experiment Videos
Cross-priming utilizes antigen not available to the direct presentation pathway.
Keri B Donohue1, Jean M Grant, Eric F Tewalt
1Department of Microbiology and Immunology, Pennsylvania State University, Milton S. Hershey College of Medicine, Hershey, PA 17033-0850, USA.
Immunology
|June 13, 2006
Summary
Direct T-cell priming requires ongoing antigen synthesis, while cross-priming utilizes long-lived antigens and does not depend on new protein production. This finding impacts vaccine design for CD8+ T cells.
Area of Science:
- Immunology
- Vaccinology
Background:
- CD8+ T cells are vital for immunity against viruses and tumors.
- Antiviral CD8+ T cells are activated via direct-priming (infected APCs) or cross-priming (exogenous antigen uptake).
- Understanding antigen processing in these pathways is key for effective vaccine development.
Purpose of the Study:
- To investigate the antigen synthesis requirements for direct-priming versus cross-priming.
- To differentiate the antigen pools utilized by these two T-cell activation pathways.
Main Methods:
- Utilized a novel T-cell receptor (TCR) transgenic mouse model.
- Examined antigen synthesis requirements during direct and cross-priming.
- Assessed the impact of protein synthesis blockade on priming pathways.
Main Results:
- Direct-priming necessitates ongoing antigen synthesis for T-cell activation.
- Cross-priming favors long-lived antigens and is independent of continuous antigen production.
- Blockade of protein synthesis in donor cells significantly impaired direct-priming but not cross-priming.
Conclusions:
- Direct- and cross-priming pathways appear to use distinct antigen sources.
- These findings have significant implications for designing vaccines to generate protective CD8+ T cell responses.